×
For best experience we recommend to activate Javascript in your browser.
RGS16 antibody (N-Term)
The Rabbit Polyclonal anti-RGS16 antibody has been validated for WB, IHC and ELISA. It is suitable to detect RGS16 in samples from Human.
Quick Overview for RGS16 antibody (N-Term) (ABIN2351006)
Target
See all RGS16 Antibodies
RGS16
(Regulator of G-Protein Signaling 16 (RGS16))
Reactivity
All reactivities for RGS16 antibodies
Human
Host
All hosts for RGS16 antibodies
Rabbit
Clonality
All clonalities for RGS16 antibodies
Polyclonal
Conjugate
All conjugates for RGS16 antibodies
This RGS16 antibody is un-conjugated
Application
All applications for RGS16 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-RGS16 Antibody
(hide)
Binding Specificity
All epitopes for RGS16 antibodies
AA 23-53, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
RGS16, NT (RGS16, RGSR, Regulator of G-protein signaling 16, A28-RGS14P, Retinal-specific RGS, Retinally abundant regulator of G-protein signaling)
Purification
Purified by Protein A affinity chromatography.
Immunogen
RGS16 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 23-53 amino acids from the N-terminal region of human RGS16.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for RGS16
(hide)
Target
RGS16
(Regulator of G-Protein Signaling 16 (RGS16))
Alternative Name
RGS16
NCBI Accession
NP_002919
UniProt
O15492
Pathways
Myometrial Relaxation and Contraction , Regulation of G-Protein Coupled Receptor Protein Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat